CONGOROSA MAYTENUS ILICIFOLIA MARF

CONGOROSA (Maytenus ilicifolia Marf. ex Reissek) +
 
Activities (Congorosa) :
- Antibacterial (1; HH2); Antisarcomic (1; HH2); Antiseptic (1; HH2; PH2); Antitumor (1; PH2); Antiulcer (1; HH2; PH2); Candidicide (1; HH2); Cytotoxic (1; PH2); Embryotoxic (1; HH2); Fungicide (1; HH2); Teratogenic (1; HH2).

Indications (Congorosa) :
- Acne (f; HH2); Alcoholism (f; PH2); Anemia (f; PH2); Asthma (f; PH2); Bacteria (1; HH2); Cancer (1; HHB; JLH; PH2); Cancer, breast (1; HH2); Cancer, head (1; HH2); Cancer, ovary (1; HH2); Cancer, skin (1; HHB; JLH; PH2); Cancer, throat (1; HH2); Candida (1; HH2); Dermatosis (1; HHB; JLH; PH2); Duodenosis (f; HH2); Dyspepsia (f; PH2); Eczema (f; HH2; PH2); Enterosis (f; PH2); Escherichia (1; HH2); Fatigue (f; PH2); Fungus (1; HH2); Gas (f; PH2); Gastrosis (f; HH2; PH2); Hodgkins Disease (1; HH2); Hyperacidity (f; PH2); Infection (1; HH2; PH2); Infection (1; HH2); Inflammation (f; PH2);
Leukemia (1; FNF; HH2); Lymphoma (1; HH2); Melanoma (1; FNF; HH2); Mycosis (1; HH2); Ophthalmia (f; PH2); Pain (f; PH2); Salmonella (1; HH2); Shigella (1; HH2); Sore (f; HH2; PH2); Staphylococcus (1; HH2); Streptococcus (1; HH2); Swelling (f; PH2); Tumor (1; PH2); Ulcer (1; HH2; PH2); Yeast (1; HH2).
Dosages (Congorosa) :
- 100 - 400 ml decoction/tea (2 - 5%) (HH2; PH2); 5 - 20 g powdered leaf (PH2); 25 - 100 ml tincture (PH2).
Contraindications, Interactions, and Side Effects (Congorosa) :
- Hazards and/or side effects not recorded for proper therapeutic dosages (PH2) Maytansines embryotoxic and teratogenic. Not for use during pregnancy. Maytenin antiseptic, antimelanomic, antitumor, and antiulcer, especially against basal cell carcinoma (PH2). Prevents ulcers in animals and humans (PH2).